← Back to Search

Procedure

Early cardiac catheterization for Cardiac Arrest

N/A
Waitlist Available
Led By Shahar Lavi, MD
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 hours
Awards & highlights
No Placebo-Only Group

Summary

This is a pilot study that will lead to a large randomized control trial (RCT), to assess whether early versus late or no cardiac catheterization is associated with improved outcomes in out-of-hospital cardiac arrest (OHCA) patients.

Eligible Conditions
  • Cardiac Arrest

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Acute kidney injury- creatinine levels
Hemoglobin, Sickle
Myocardial infarction - according to cardiac troponin levels
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Medical armActive Control1 Intervention
Initial therapy does not include cardiac catheterization. Cardiac catheterization with possible PCI is allowed after completion of mild therapeutic hypothermia or apyrexia for \>24h post ROSC.
Group II: Early cardiac catheterizationActive Control1 Intervention
Cardiac catheterization performed as early as possible, within 12h post ROSC following OHCA, with possible PCI during mild therapeutic hypothermia or apyrexia

Find a Location

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor
677 Previous Clinical Trials
421,552 Total Patients Enrolled
1 Trials studying Cardiac Arrest
15 Patients Enrolled for Cardiac Arrest
Shahar Lavi, MDPrincipal InvestigatorLondon Health Sciences Centre
6 Previous Clinical Trials
1,479 Total Patients Enrolled
~9 spots leftby Nov 2025